MedTrace Logo

Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals

NCT04254731 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-04-03

No results posted yet for this study

Summary

Effects of switching from racemic methadone to R-methadone on serum methadone concentrations and QTc intervals

Conditions

  • Adverse Drug Effect
  • Drug Effect
  • Heart Arrhythmia

Interventions

DRUG

Same individuals treated with racemic methadone and switched to levomethadone (R-methadone)

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Mimi Stokke S Opdal, MD, PhD · Oslo University Hospital and University of Oslo

  • Peter Krajci, MD, PhD · Oslo University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-07
Primary Completion
2018-06-27
Completion
2024-07-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04254731 on ClinicalTrials.gov